Dashboard
Manage Tickers

SLN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

correction-silence-therapeutics-q3-epads-045-misses-028-estimate-sales-159000k-miss-4414m-estimate
CORRECTION: Silence Therapeutics Q3 EPADS ...
11/06/2025 14:35:55

Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of...

silence-therapeutics-completes-patient-enrollment-in-phase-2-study-of-divesiran
Silence Therapeutics Completes Patient Enr...
10/23/2025 11:34:56

Silence Therapeutics plc (NASDAQ:SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 21:06:33

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/21/2025 12:10:04

hc-wainwright--co-reiterates-buy-on-silence-therapeutics-maintains-75-price-target
HC Wainwright & Co. Reiterates Buy on Sile...
09/16/2025 10:49:37

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $7...

chardan-capital-maintains-buy-on-silence-therapeutics-maintains-35-price-target
Chardan Capital Maintains Buy on Silence T...
08/08/2025 11:57:30

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $35 price target.

correction-silence-therapeutics-q2-eps-057-misses-023-estimate-sales-224000k-miss-5430m-estimate
CORRECTION: Silence Therapeutics Q2 EPS $(...
08/07/2025 14:10:44

Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of...

hc-wainwright--co-reiterates-buy-on-silence-therapeutics-maintains-75-price-target
HC Wainwright & Co. Reiterates Buy on Sile...
06/13/2025 11:21:19

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

chardan-capital-maintains-buy-on-silence-therapeutics-maintains-35-price-target
Chardan Capital Maintains Buy on Silence T...
06/13/2025 10:50:49

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $35 price target.

silence-therapeutics-presents-additional-data-showcasing-sanreco-phase-1-study-of-divesiran-in-patients-with-pv-at-eha-2025-annual-meeting
Silence Therapeutics Presents Additional D...
06/12/2025 20:02:22

Updated Phase 1 Data Presented at EHA 2025 Annual Meeting Reinforce Safety Profile, Efficacy Data and Dosing Convenience of Div...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 21:05:58

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/13/2025 12:10:18

goldman-sachs-maintains-sell-on-silence-therapeutics-lowers-price-target-to-3
Goldman Sachs Maintains Sell on Silence Th...
05/09/2025 18:13:56

Goldman Sachs analyst Richard Law maintains Silence Therapeutics (NASDAQ:SLN) with a Sell and lowers the price target from ...

morgan-stanley-maintains-overweight-on-silence-therapeutics-lowers-price-target-to-25
Morgan Stanley Maintains Overweight on Sil...
05/09/2025 15:57:01

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and lowers the price target...

chardan-capital-maintains-buy-on-silence-therapeutics-lowers-price-target-to-35
Chardan Capital Maintains Buy on Silence T...
05/09/2025 10:45:46

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:SLN) with a Buy and lowers the price target from $...

update-silence-therapeutics-q1-epads-060-sales-14200k
UPDATE: Silence Therapeutics Q1 EPADS $(0....
05/08/2025 14:08:09

hc-wainwright--co-reiterates-buy-on-silence-therapeutics-maintains-75-price-target
HC Wainwright & Co. Reiterates Buy on Sile...
03/07/2025 11:59:10

HC Wainwright & Co. analyst Patrick Trucchio reiterates Silence Therapeutics (NASDAQ:SLN) with a Buy and maintains $75 p...

morgan-stanley-maintains-overweight-on-silence-therapeutics-lowers-price-target-to-45
Morgan Stanley Maintains Overweight on Sil...
03/05/2025 14:08:57

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight and lowers the price target...

deep-dive-into-silence-therapeutics-stock-analyst-perspectives-7-ratings
Deep Dive Into Silence Therapeutics Stock:...
03/04/2025 21:01:16

bmo-capital-maintains-outperform-on-silence-therapeutics-lowers-price-target-to-25
BMO Capital Maintains Outperform on Silenc...
03/04/2025 17:57:14

BMO Capital analyst Kostas Biliouris maintains Silence Therapeutics (NASDAQ:SLN) with a Outperform and lowers the price targ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION